- Trials with a EudraCT protocol (8)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
8 result(s) found for: Collagenous colitis.
Displaying page 1 of 1.
EudraCT Number: 2006-004159-39 | Sponsor Protocol Number: BUC-60/COC | Start Date*: 2007-03-15 | |||||||||||
Sponsor Name:Dr. Falk Pharma GmbH | |||||||||||||
Full Title: Double-blind, double-dummy, randomised, placebo-controlled, multi-centre phase III clinical study on the efficacy and tolerability of budesonide capsules vs. mesalazine granules vs. placebo for pat... | |||||||||||||
Medical condition: Collagenous colitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) ES (Completed) LT (Completed) DK (Completed) GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-001891-39 | Sponsor Protocol Number: version4.6,29082018 | Start Date*: 2018-09-14 | |||||||||||
Sponsor Name:XiCoCo study group | |||||||||||||
Full Title: Rifaximin-treatment of Collagenous colitis: A prospective, double-blind, placebo-controlled study | |||||||||||||
Medical condition: Collagenous Colitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-001315-31 | Sponsor Protocol Number: BUC-63/COC | Start Date*: 2008-03-13 | |||||||||||
Sponsor Name:Dr. Falk Pharma GmbH | |||||||||||||
Full Title: Double-blind, randomised, placebo-controlled, multi-centre phase III clinical study on the efficacy and tolerability of budesonide capsules versus placebo for maintenance of remission in patients w... | |||||||||||||
Medical condition: Collagenous colitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) DE (Completed) HU (Completed) DK (Completed) CZ (Completed) BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-017240-14 | Sponsor Protocol Number: 2010/109 | Start Date*: 2012-06-21 | |||||||||||||||||||||
Sponsor Name:ASOCIACIÓN GALLEGA DE ENFERMEDAD INFLAMATORIA INTESTITAL (E.I.G.A.) | |||||||||||||||||||||||
Full Title: EFFICACY OF BECOMETASONE DIPROPIONATE ON MICROSCOPIC COLITIS | |||||||||||||||||||||||
Medical condition: Microscopic colitis | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-004216-36 | Sponsor Protocol Number: BDPCC | Start Date*: 2017-03-09 | |||||||||||
Sponsor Name:I.R.C.C.S. POLICLINICO SAN DONATO | |||||||||||||
Full Title: Pilot, open-label, spontaneous, Phase II study on the efficacy of beclomethasone dipropionate (BDP) for treatment of Collagenous colitis (CC) | |||||||||||||
Medical condition: collagenous colitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-001912-31 | Sponsor Protocol Number: BUG-3/MIC | Start Date*: 2014-02-19 | |||||||||||
Sponsor Name:Dr. Falk Pharma GmbH | |||||||||||||
Full Title: Randomised, double-blind, placebo-controlled, multi-centre trial on the efficacy and safety of budesonide for induction of remission in incomplete microscopic colitis | |||||||||||||
Medical condition: Patients with active incomplete microscopic colitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) HU (Completed) ES (Completed) SE (Completed) NL (Prematurely Ended) DK (Completed) LT (Completed) PT (Completed) AT (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-002762-12 | Sponsor Protocol Number: SJ-674 | Start Date*: 2021-12-07 |
Sponsor Name:Zealand University Hospital | ||
Full Title: The prevalence of bile acid diarrhéa and the effect of budesonid on the bile acid homeostasis in patients with microscopic colitis | ||
Medical condition: Microscopic colitis Bile acid diarrhea | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DK (Completed) | ||
Trial results: View results |
EudraCT Number: 2015-004063-36 | Sponsor Protocol Number: CELIM-RCD-002 | Start Date*: 2016-02-22 |
Sponsor Name:Celimmune LLC | ||
Full Title: A Phase 2a, Randomized, Double-Blind, Placebo Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of AMG 714 in Adult Patients with Type II Refractory Celiac Disease, an In Situ Sm... | ||
Medical condition: Type II Refractory Celiac Disease (RCD-II) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FI (Completed) NL (Completed) ES (Completed) | ||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
